{"id":2031,"date":"2023-04-07T09:47:14","date_gmt":"2023-04-07T15:47:14","guid":{"rendered":"https:\/\/irega.com.mx\/blog\/?p=2031"},"modified":"2023-07-11T19:10:03","modified_gmt":"2023-07-12T01:10:03","slug":"cacu-cancer-cervicouterino","status":"publish","type":"post","link":"https:\/\/irega.com.mx\/blog\/2023\/04\/07\/cacu-cancer-cervicouterino\/","title":{"rendered":"CACU: C\u00e1ncer Cervicouterino"},"content":{"rendered":"<p>El C\u00e1ncer Cervicouterino, seg\u00fan la OMS, es la enfermedad m\u00e1s frecuente en la mujer en la etapa reproductiva, que tiene una alta Tasa de Mortalidad, en comparaci\u00f3n con cualquier otro tipo de c\u00e1ncer, de acuerdo con la estad\u00edstica mundial y GLOBOCAN (Global Cancer Observatory) en el\u00a02020 report\u00f3 9,439 de casos nuevos de mujeres \u00f3sea un 8.9 % de mexicanas por cada 100, 000 habitantes que representan 4.8 % defunciones coloc\u00e1ndolo dentro de los 10 primeros c\u00e1nceres.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-2033 aligncenter\" src=\"https:\/\/irega.com.mx\/blog\/wp-content\/uploads\/2023\/04\/Diseno-sin-titulo123213131.png\" alt=\"\" width=\"221\" height=\"221\" srcset=\"https:\/\/irega.com.mx\/blog\/wp-content\/uploads\/2023\/04\/Diseno-sin-titulo123213131.png 250w, https:\/\/irega.com.mx\/blog\/wp-content\/uploads\/2023\/04\/Diseno-sin-titulo123213131-150x150.png 150w, https:\/\/irega.com.mx\/blog\/wp-content\/uploads\/2023\/04\/Diseno-sin-titulo123213131-180x180.png 180w, https:\/\/irega.com.mx\/blog\/wp-content\/uploads\/2023\/04\/Diseno-sin-titulo123213131-60x60.png 60w\" sizes=\"auto, (max-width: 221px) 100vw, 221px\" \/><\/p>\n<p>El cual es prevenible y como suele ser de costumbre como no se siente, no duele, nadie me hab\u00eda dicho nada a pesar de toda la informaci\u00f3n disponible gratuita.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-2036 alignleft\" src=\"https:\/\/irega.com.mx\/blog\/wp-content\/uploads\/2023\/04\/vacuna-vph.png\" alt=\"\" width=\"133\" height=\"133\" srcset=\"https:\/\/irega.com.mx\/blog\/wp-content\/uploads\/2023\/04\/vacuna-vph.png 250w, https:\/\/irega.com.mx\/blog\/wp-content\/uploads\/2023\/04\/vacuna-vph-150x150.png 150w, https:\/\/irega.com.mx\/blog\/wp-content\/uploads\/2023\/04\/vacuna-vph-180x180.png 180w, https:\/\/irega.com.mx\/blog\/wp-content\/uploads\/2023\/04\/vacuna-vph-60x60.png 60w\" sizes=\"auto, (max-width: 133px) 100vw, 133px\" \/>Sin saber que uno de los primeros riesgos son el n\u00famero de parejas sexuales que tuvieron sexo desprotegido contagiado del VPH que nos pudiera ocasionar lesiones pre cancerosas que son ocasionados por serotipos de alto riesgo y que es prevenible con la Vacuna del VPH que se aplica a ambos sexos en etapas tempranas de la vida o ahora mismo en pareja que puede tambi\u00e9n tratar el VPH.<\/p>\n<p>Como podemos disminuir el riesgo de CACU:<\/p>\n<ul>\n<li>Vacun\u00e1ndonos a m\u00ed, pareja e hijos (Completando el esquema de vacunaci\u00f3n)<\/li>\n<li>Realizando anualmente mi papanicolaou y colposcopia<\/li>\n<li>Visitando cada 6 meses o anualmente a mi ginec\u00f3logo para recibir mis recomendaciones de acuerdo con mi estado de salud a pesar de que no est\u00e9 enferma.<\/li>\n<li>Realizando estudios diagn\u00f3sticos a m\u00ed y a mi pareja enfocando en la b\u00fasqueda del VPH.<\/li>\n<li>Existen Gel (aplicadores vaginales) que promueven la relativizaci\u00f3n del VPH y mejorar las condiciones actuales.<\/li>\n<li>Hacer caso al especialista y no a la comadre, amiga, comadre o la que nunca acude al m\u00e9dico.<\/li>\n<li>Siendo responsables de nuestra propia salud.<\/li>\n<\/ul>\n<p style=\"text-align: center;\"><span style=\"color: #ff0000; font-size: 24px;\"><em>Realiza una cita para mayores informes y un tratamiento personalizado.<\/em><\/span><\/p>\n<p style=\"text-align: center;\"><i class=\"uk-icon-phone\"><\/i><span style=\"font-size: 16px; color: #ff0000;\"><a style=\"color: #ff0000;\" href=\"tel:9988021515\">(998) 802 1515<\/a> &#8211;\u00a0<i class=\"uk-icon-phone\"><\/i><a style=\"color: #ff0000;\" href=\"tel:9988021516\">(998) 802 1516<\/a><\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-2032\" src=\"https:\/\/irega.com.mx\/blog\/wp-content\/uploads\/2023\/04\/IREGA-doctores1.png\" alt=\"\" width=\"180\" height=\"178\" srcset=\"https:\/\/irega.com.mx\/blog\/wp-content\/uploads\/2023\/04\/IREGA-doctores1.png 180w, https:\/\/irega.com.mx\/blog\/wp-content\/uploads\/2023\/04\/IREGA-doctores1-60x60.png 60w\" sizes=\"auto, (max-width: 180px) 100vw, 180px\" \/><\/p>\n<p>Dr. Bryan A. Oliveros Galeana<br \/>\nDirector IREGA Canc\u00fan<br \/>\nJefe del Servicio de Medicina de la Reproducci\u00f3n<\/p>\n<blockquote><p><strong>Referencias:<\/strong><\/p>\n<p><span style=\"font-size: 8px;\">1. Organizaci\u00f3n Mundial de la Salud., Control integral del c\u00e1ncer cervicouterino.Gu\u00eda de pr\u00e1cticas esenciales. Organizaci\u00f3n Panamericana de la Salud. Segunda edici\u00f3n 2016.<\/span><\/p>\n<p><span style=\"font-size: 8px;\">2. World Health Organization. Globocan 2020 [internet]. Disponible en https:\/\/gco.iarc.fr\/today\/data\/factsheets\/populations\/484-mex-ico-fact-sheets.pdf.<\/span><\/p>\n<p><span style=\"font-size: 8px;\">3. Huber, J., Mueller, A., Sailer, M., &amp; Regidor, P. A. (2021). Human papillomavirus persistence or clearance after infection in reproductive age. What is the status? Review of the literature and new data of a vaginal gel containing silicate dioxide, citric acid, and selenite. Women&#8217;s health (London, England), 17, 17455065211020702. https:\/\/doi.org\/10.1177\/17455065211020702<\/span><\/p>\n<p><span style=\"font-size: 8px;\">4. Frank, L. A., Gazzi, R. P., de Andrade Mello, P., Buffon, A., Pohlmann, A. R., &amp; Guterres, S. S. (2019). Imiquimod-loaded nanocapsules improve cytotoxicity in cervical cancer cell line. European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 136. 9-17. https:\/\/doi.org\/10.1016\/j.ejpb.2019.01.001<\/span><\/p>\n<p><span style=\"font-size: 8px;\">5. Huber, J., P\u00f6tsch, B., Gantschacher, M., &amp; Templ, M. (2016). Routine Treatment of Cervical Cytological Cell Changes: Diagnostic Standard, Prevention and Routine Treatment of Cervical Cytological Cell Changes &#8211; An Assessment of Primary and Secondary Prevention and Routine Treatment Data in the Context of an Anonymous Data Collection from Practicing Gynecologists; an Academic, Non-Interventional Study. Geburtshilfe und Frauenheilkunde, 76(10), 1086-1091. https:\/\/doi.org\/10.1055\/s-0042-105286.<\/span><\/p>\n<p><span style=\"font-size: 8px;\">6. Major, A. L., Dvoti\u00e1k, V., Schwarzov\u00e1, J., Skiiv\u00e1nek, A., Malik, T., Pluta, M., Mayboroda, I., &amp; Grandjean, E. M. (2021). Efficacy and safety of an adsorbent and anti-oxidative vaginal gel on CIN1 and 2, on high-risk HPV, and on p16\/Ki-67: a randomized controlled trial. Archives of Gynecology and Obstetrics, 303(2), 501-511. https:\/\/doi.org\/10.1007\/500404-020-05816-8\/TABLES\/3<\/span><\/p>\n<p><span style=\"font-size: 8px;\">7. Sailer M., Mueller A., Regidor PA. (2021). Real-life experience of the vaginal gel DeflaGyn\u00ae in Germany. En: European Gynecology &amp; Obstetrics. $1. 2021.PP:127.<\/span><\/p>\n<p><span style=\"font-size: 8px;\">8. Major, A. L., Skiiv\u00e1nek, A, Grandjean, E. M., Dvoli\u00e4k, V., Malik, T., Pluta, M., &amp; Mayboroda, I. (2021). An Adsorptive and Antioxidant Vaginal Gel Clears High-Risk HPV- and p16\/Ki-67-Associated Abnormal Cytological Cervical Findings: A post-hoc Subgroup Analysis of a Prospective Randomized Controlled Trial on CIN2 and p16 Positive CIN1. Frontiers in medicine, 8, 645559. https:\/\/-dol.org\/10.3389\/fmed.2021.645559.<\/span><\/p>\n<p><span style=\"font-size: 8px;\">9. Pharma Trend. (2021). Pharma Award. https:\/\/pharma-trend.com\/en\/phar-ma-award\/#8220The_Golden_Tablet8221_2021_Award_Recipients<\/span><\/p>\n<p><span style=\"font-size: 8px;\">10. CORNE. DEFLAGYN Gel. Consultado 29 mayo, 2022, en https:\/\/www.me dicamentospim.com\/Home\/productos\/deflagyn_gel\/44\/101\/69716\/66<\/span><\/p><\/blockquote>\n","protected":false},"excerpt":{"rendered":"<p>El C\u00e1ncer Cervicouterino, seg\u00fan la OMS, es la enfermedad m\u00e1s frecuente en la mujer en la etapa reproductiva, que tiene una alta Tasa de Mortalidad, en comparaci\u00f3n con cualquier otro&#8230; <a href=\"https:\/\/irega.com.mx\/blog\/2023\/04\/07\/cacu-cancer-cervicouterino\/\">Leer m\u00e1s &raquo;<\/a><\/p>\n","protected":false},"author":1,"featured_media":2034,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2,39,88],"tags":[],"class_list":["post-2031","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biologia-de-la-reproduccion","category-fertilidad","category-ginecologia"],"_links":{"self":[{"href":"https:\/\/irega.com.mx\/blog\/wp-json\/wp\/v2\/posts\/2031","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irega.com.mx\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/irega.com.mx\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/irega.com.mx\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/irega.com.mx\/blog\/wp-json\/wp\/v2\/comments?post=2031"}],"version-history":[{"count":4,"href":"https:\/\/irega.com.mx\/blog\/wp-json\/wp\/v2\/posts\/2031\/revisions"}],"predecessor-version":[{"id":2071,"href":"https:\/\/irega.com.mx\/blog\/wp-json\/wp\/v2\/posts\/2031\/revisions\/2071"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/irega.com.mx\/blog\/wp-json\/wp\/v2\/media\/2034"}],"wp:attachment":[{"href":"https:\/\/irega.com.mx\/blog\/wp-json\/wp\/v2\/media?parent=2031"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/irega.com.mx\/blog\/wp-json\/wp\/v2\/categories?post=2031"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/irega.com.mx\/blog\/wp-json\/wp\/v2\/tags?post=2031"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}